期刊文献+

前列腺增生症对前列腺特异抗原的影响 被引量:4

下载PDF
导出
出处 《标记免疫分析与临床》 CAS 2000年第1期50-51,共2页 Labeled Immunoassays and Clinical Medicine
  • 相关文献

参考文献6

  • 1OesterlingJE.Prostatespecificantigen:acriticalassessmentofthemostusefultumormarkerofadenocareinomaoftheprostate.JUrol,1991;145:907.
  • 2FrroMA,BarrseI,RobertsJBetal.Tumormarkersinprostaticcarcinoma:acomparisonofprostatespecificantigenwithacidphophatase.BritJUrol,1987;60:69
  • 3WberJP,OesterlingJE,PetersCAetal.Prostatespecificantigenasaserummarkerforadenocarcinomaoftheprostate.NewEnglJMed,1987;317:909
  • 4CollinsGN,LeeRJ,MckelvieGBetal.Relationshipbetweenprostatespecific-antigen,prostatevolumeandageinthebenignprostatehypertrophy.BrJUrol,1993,71;445
  • 5StameyTA,KabalinJN,McneelJEetal.Prostatespecific-antiganinthediagnosisandtreatmentofadenocarcinomaoftheprostate.JUrol,1989;141:1076
  • 6BabainRJ,MiyashitaH,EvansRBetal.Th,edistributionofprostatespecific-antigeninmenwithoutclinicalorpathologicalevidenceofprostatecancer:relationshiptoglangvolumeandage.JUrol,1992;147:837

同被引文献18

  • 1Stenman VII, Leinonen J, et al. antigen and alpha-antichymotrypsin. A complex between prostate-specific Is the major form of prostate specific antigen in serum of patients with prostate cancer: Assay of the complex improves clinical sensitivity for cancer[J]. Cancer Res, 1991, 51 : 222-226.
  • 2Stenman VH, Leinonen J. A complex between prostate - specific antigen and alpha- antichymotrypain. Is the major form of prostate specific antigen in serum of patients with prostate cancer: Assay of the complex improves clinical sensitivity for caner[J]. Cancer Res, 1991, 51 : 222 - 226.
  • 3Stenman VH,Leinonen J.A complex between prostate-specific antigen and alpha-antichymotrypsin.Is the major form of prostate specific antigen in serum of patients with prostate cancer:assay of the complex improves clinical sensitivity for caner.Cancer Res,1991,51:222~226.
  • 4Sershon PD,Barry MJ,Oesterling JE.Serum prostate-specific antigen discriminates weakly between men with benign prostatic byperplasia and patients with organ confined prostate cancer[J].Eur Uro1,1994,25(4):281 287.
  • 5Kang SH, Bae JH,Park HS,et al.Prostate-specific antigen adjusted for the transition zone volume as a second screening test.a prospective study of 248 cases[J].Int J Urol,2006,13(7)910- 914.
  • 6Kim KS,Jeong WS,Park SY,et al.The effect of two weeks of treatment with dutasteride on bleeding after transurethral resection of the prostate[J].World J Mens Health, 2015 , 33(1) :14- 19.
  • 7kuriyama M, Wang MC, Papsidero LD. Quantitation of Prostate specific antigen in serurm by a sensitive enzyme immunoassay[J].Cancer Res, 1980,40(12): 4658 -4662.
  • 8Bjork T,Piironen T,Pettersson K.Comparison of analysis of the different prostate specific antigen of in mrum for detection of clinically localized prostate cancer[J]. Urology, 1996,48(6); 8824 -888.
  • 9Stenman UH,Leinonen J,Alfthan H,et al.A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer:assay of the complex improves clinical sensitivity for cancer[J].Cancer Res, 1991, 51(1):222-226.
  • 10SEAMAN E,WHANG IS,OLSSON CA,et al. PSA density:role in patients evaluation and management[J]. Urol Clin N Am, 1993,20.653- 660.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部